We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M Turnover 12.28%
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+0.83%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.08%
10 Year Est. Return
+563.15%
AUM
$446M
AUM Growth
+$1.07M
Cap. Flow
+$158K
Cap. Flow %
0.04%
Top 10 Hldgs %
42.95%
Holding
52
New
1
Increased
–
Reduced
2
Closed
–
Avg Time Held
4.2 years
Top 10 Avg Time Held
2.1 years
Top 20 Avg Time Held
3.3 years

Top Buys

Rank Stock Value
1
VNT icon
Vontier
VNT
+$204K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$31.4K
2
PYPL icon
PayPal
PYPL
+$14.2K

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Healthcare 20.72%
3 Industrials 16.56%
4 Consumer Discretionary 12.21%
5 Communication Services 12.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SJM icon
51
J.M. Smucker
SJM
$13.5B
$204K 0.05%
1,700
– –
2021 Q1
2 quarters
VNT icon
52
Vontier
VNT
$4.5B
$202K 0.05%
+6,000
New +$204K
2021 Q3
0 quarters

Similar funds

Chad R. Baker's Q3 2021 Portfolio in Review

As of Q3 2021, Chad R. Baker held 52 positions worth $446M, up 0.24% from $445M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 1.9%. Chad R. Baker opened 1 new position and made no exits, leaving the 52-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Chad R. Baker's largest Q3 2021 buy was Vontier: 6,000 shares worth $202K.
  • Chad R. Baker's biggest Q3 2021 reduction was CVS Health, cutting an estimated $31.4K.
  • Chad R. Baker's ten largest holdings make up 43% of its $446M portfolio in Q3 2021.
  • Chad R. Baker opened 1 new position and closed 0 in Q3 2021.
  • Chad R. Baker's portfolio value rose 0.24% quarter-over-quarter to $446M.

Based on Chad R. Baker's 13F filing for Q3 2021, filed 8 Nov 2021.